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1. Introduction 
TPCK has been reported to be an inhibitor of pro- 
tein synthesis in E. coli and Bacillus stearothemo- 
philus [l-3]. Recently, it has been shown to inhibit 
specifically the EF-T mediated binding of Phe-tRNA 
to the ribosome by irreversibly destroying the ability 
of EF-Tu* GTP to combine with Phe-tRNA and form 
the ternary complex [4]. The studies reported here 
confirm the earlier findings that TPCK inhibits only 
EF-Tu function in a homologous bacterial system and 
extend the observation by demonstrating that: TPCK 
also inhibits the function of EF-Tu in a heterologous 
bacterial-avian system but does not inhibit EF-1 func- 
tion in either a homologous avian or mammalian sys- 
tem. 
2. Materials and methods 
Bacterial ribosomes were prepared as previously 
described [S]. EF-Tu, EF-Ts and EF-G were prepared 
according to the method of Arai et al. [6], and puri- 
fied through the G-100 step. The units of EF-Ts, 
EF-Tu and EF-G are as defined by Arai et al. [6]. 
Labelled Phe-tRNA was made by the method of Con- 
way [7]. Avian ribosomes were prepared from chicken 
livers by a preparative adaptation of the method of 
Adelman et al. [S] for direct isolation of ribosomal 
subunits from the microsomal fraction [9]. EF-1 was 
prepared from the S-100 of the same cells by succes- 
sive ammonium sulfate precipitation, Sephadex G-200 
and hydroxyapatite steps, based on McKeehan and 
Hardesty [lo]. 
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Rabbit reticulocyte ribosomes and S-100 were 
prepared as described previously by Bulova and Burka 
[ 111. TPCK was purchased from Serva, poly U from 
Miles, GTP from Boehringer, [3H]Phe (specific activ- 
ity of 12 Ci/mmole), [14C]Phe (specific activity of 
5 13 mCi/mmole) from Amersham and [ l4 C]Val 
(specific activity 207 mCi/mmole) from New England 
Nuclear. 
3. Results and discussion 
As shown in table 1, TPCK treatment of a bacterial 
S-100 completely inactivates it for polyphenylalanine 
synthesis. To determine the specificity of this inhibi- 
tion, three separate reactions were carried out in which 
an S-100, treated with TPCK, was supplemented with 
either EF-Tu, EF-Ts or EF-G and the extent of poly- 
phenylalanine synthesis measured. Only the addition 
of EF-Tu, table 1, restored activity. Addition of excess 
EF-Ts or EF-G was without effect. 
Since TPCK specifically inactivated EF-Tu, we 
sought to determine if the analogous enzyme in a 
eucaryotic system would also be inhibited. We mea- 
sured, therefore, EF-1 dependent Phe-tRNA binding, 
in the presence and absence of TPCK, in a system 
derived from chicken liver. In a parallel control exper- 
iment, EF-Tu dependent Phe-tRNA binding to E. coli 
ribosomes was measured under the identical condi- 
tions. The results of both experiments are shown in 
table 2. EF-Tu dependent binding is essentially com- 
pletely inhibited, while EF-1 dependent binding is 
unaffected. 
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Table 1 Table 3 
The effect of TPCK on polyphenylalanine synthesis in an 
E. coli synthesizing system. 
The effect of TPCK on protein synthesis in a reticulocyte 
cell-free system. 
Treatment pmoles [ “C]Phenylalanine 
incorporated 
Control S-100 2.6 
TPCK treated S-100 0.0 
TPCK treated S-100 + EF-Tu 4.5 
TPCK treated S-100 + EF-Ts 0.2 
TPCK treated S-100 + EFG 0.1 
Reaction mixtures contained in 50 rl, 50 mM Tris-HCl 
(pH 7.4), 0.16 M NH4Cl, 10 mM MgCl2,l mM DTT, 50 
nmoles GTP, 2 pg [14C]Phe-tRNA (containing 7.1 pmoles 
Phe), 2 pg S-100 protein, 1.4 pmoles ribosomes, and 1 unit 
of EF-Tu, 20 units of EF-Ts or 250 units of EF-G, where in- 
dicated. Incubation was for 10 min at 30°C. The S-100 was 
treated with a 1:20 dilution of 10 mM TPCK in methanol in 
20 mM Tris-HCl (pH 7.4), 10 mM MgCls, 1 mM DTT, and 
10 PM GDP. It was treated 10 min at ambient temperature 
and then 2 ~1 was added to the reaction mixture. The control 
S-100 was treated similarly with methanol only. 
Table 2 
The effect of TPCK treatment on enzymatic Phe-tRNA 
binding. 
System employed Percent of untreated 
control 
Homologous E. di 8 
Homologous avian 100 
Heterologous E. coli-avian 4 
Each reaction mixture contained in 50 ccl, 50 mM Qis-HCl 
(pH 7.4), 60 mM NH4Cl, 8 mM MgCl2,lO mM DTT, 2 nmoles 
GTP, 10 r.rg poly U and 20 Irg [3H]Phe-tRNA (containing 7.1 
pmole Phe). In the homologous bacterial system 8 pmoles of 
ribosomes, 1 unit of EF-Tu and 20 units of EF-Ts were also 
present. In the homologous avian system 5 pmoles of ribo- 
somes and 0.6 units of EF-1 were present. One unit of EF-1’ 
is defined as the amount of enzyme which catalyzes the bind- 
ing of 1 pmole of Phe-tRNA in 5 mln at 0°C. In the heterolo- 
gous bacterial-avian system 5 pmoles of avian ribosomes, 
1 unit of EF-Tu and 20 units of EF-Ts were present. TPCK 
treatment of EF-Tu or EF-1 was as described in table 1. The 
amount of Phe-tRNA bound was measured after an incubation 
of 5 min at 0°C. The values reported are percentages of control 
reactions treated with methanol only. The binding in the con- 
trol systems were: homologous bacterial 0.1 pmole Phe-tRNA 
bound/pmole ribosome, homologous avian 0.04 pmole Phe- 
tRNA bound/pmole ribosome and heterologous avian-bacterial 
0.03 pmole Phe-tRNA bound/pmole ribosome. 
Treatment pmoles [ t4C]Valine 
incorporated 
Control system 5.8 
TPCK treated S-100 6.7 
TPCK treated ribosomes 6.0 
The incorporation of [ 14C]Val into protein was assayed in 
the reticulocyte cell-free system previously described by 
Bulova and Burka [lo]. Incubation was for 45 min at 37°C. 
Each 200 ~1 reaction contained 3 A2eo units of ribosomes 
and 10 r.d of ribosome-free supernatant (S-100) as a source 
of soluble factors and tRNA. TPCK treatment of ribosomes 
or S-l 00 was as described in table 1. 
Since it had been shown by Krisko et al. [ 121 that 
EF-Tu could function in a heterologous procaryote- 
eucaryote system, we thought it of interest to measure 
the effect of TPCK on this activity of EF-Tu. To do 
this, we prepared a heterologous bacterial-avian sys- 
tem composed of EF-Tu, EF-Ts and chicken liver ribo- 
somes and measured the effect of TPCK on Phe-tRNA 
binding. The results of such an experiment are also 
shown in table 2. EF-Tu function in this system is 
completely inhibited as in the homologous bacterial 
system. 
Finally, we sought to determine the effect of 
TPCK in a mammalian system. We employed a reti- 
culocyte cell-free synthesizing system and compared 
the level of synthesis in a control reaction with that 
in which either the S-100 or ribosomes were treated 
with TPCK prior to polymerization. As can be seen 
in table 3, TPCK treatment is without effect, consis- 
tent with our observations in the avian system. 
The fact that EF-Tu can substitute for EF-1 in 
either polyphenylalanine synthesis or Phe-tRNA bind- 
ing, suggests that some homology exists between the 
two factors [2]. It therefore seemed of interest to 
determine whether TPCK, a reported inhibitor of 
EF-Tu function, would also inhibit EF-1. The results 
reported here show that although TPCK does inhibit 
EF-Tu activity in a heterologous bacterial-avian sys- 
tem, it does not inhibit EF-1 in either an avian or 
mammalian bacterial-avian system. TPCK is thus 
non-toxic for eucaryote protein synthesis. This is of 
interest in relation to the current use of protease in- 
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hibitors as tools in the elucidation of the mechanism 
of the expression of malignancy [13-151. 
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